Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractantprotein-1 production
S. Hess et al., Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractantprotein-1 production, J IMMUNOL, 165(4), 2000, pp. 1939-1948
IL-6 is synthesized in human pampilloma virus (HPV)-transformed cervical ca
rcinoma cell lines and is supposed to stimulate these cells in an autocrine
manner. We studied IL-6 production and responsiveness in nonmalignant HPV-
transformed keratinocytes and cervical carcinoma cells in detail. IL-6 was
detected in cervical carcinomas in situ. Correspondingly, HPV-positive carc
inoma cell lines expressed high IL-6 levels. However, these carcinoma cell
lines showed low responsiveness to IL-6 as revealed by low constitutive STA
T3 binding activity, which was not further enhanced by exogenous IL-6. In c
ontrast, in vitro-transformed nonmalignant keratinocytes without endogenous
IL-6 production strongly responded to exogenous IL-6 with activation of ST
AT3. STAT3 protein expression levels were comparable in both responsive and
nonresponsive cell lines. Also, gp130, the upstream signal-transducing rec
eptor subunit conveying IL-6 signals into the cell, was expressed in all te
sted cell lines. However, the IL-6 binding subunit gp80 was lost in the mal
ignant cells. Addition of soluble gp80 was sufficient to restore IL-6 respo
nsiveness in carcinoma cells as shown by enhanced activation of STAT3 bindi
ng activity. As a consequence of the restored IL-6 responsiveness, carcinom
a cells strongly produced the chemokine monocyte chemoattractant protein-1
(MCP-1). Our data demonstrate that cervical carcinoma cells producing high
amounts of IL-6 only weakly respond to IL-6 in an autocrine manner due to l
imited gp80 expression. While production of IL-6 might contribute to a loca
l immunosuppressive effect, silencing an autocrine IL-6 response prevents c
onstitutive production of the mononuclear cell-attracting chemokine MCP-1.
Both mechanisms might help the tumor to escape the immune system.